our regimen. This treatment was begun immediately after the diagnosis had been established. The treatment'2 consisted of (1) paracentesis of the anterior chamber under the slit-lamp biomicroscope with topical anaesthesia and the use of a tuberculin syringe and 27 gauge needle; (2) controlled ocular massage using a fundus contact lens while visualising the retinal vessels at the disc; (3) inhalational therapy with a 95% oxygen/5% carbon dioxide mixture administered by mask for 10 minutes every hour during the waking hours and every 4 hours during the night; and (4) oral administration of acetazolamide (250 mg q.i.d.) and aspirin (10 grains (65 mg) b.i.d.). Every patient underwent a complete physical examination with emphasis on the cardiovascular system. A complete blood count, an erythrocyte sedimentation rate, a serum lipid profile, a fasting blood glucose, an electrocardiogram, and a chest x-ray were obtained on admission. Inhalation therapy was discontinued after 48 to 72 hours, but acetazolamide and aspirin were continued for at least 2 weeks. These drugs were then discontinued unless another indication for their continued use existed. Drugs and dosages for the associated systemic disorders were managed by the internist.
Complete ophthalmic examination was repeated prior to hospital discharge and again at follow-up 1 month or more after treatment. Early (1-2 days) and late (over 2 weeks) post-treatment fluorescein angiograms and electroretinograms were obtained in many of the cases in order to assess the changes in retinal perfusion and electrical retinal responsiveness.
Results
Thirty-two patients were included in the study. Visual prognosis following treatment of acute central retinal artery obstruction '3 On the other hand all our patients studied by pretreatment fluorescein angiography showed delayed retinal arterial filling and a prolonged interval between initial choroidal flush and retinal arterial filling. Furthermore, some of the angiograms showed evidence of abnormal choroidal filling as well.
Comments
Our results suggested that the prognosis for visual acuity in acute central retinal artery obstruction may not be as dismal as previously believed.
The observation that some of our patients recovered a significant degree of visual acuity indicates that these patients had at least partially reversible impairment of retinal function at the time of presentation. The degree of reversibility appeared to correlate with presenting visual acuity and duration of visual impairment. Fig. I shows the interrelationship between these 2 factors and final visual acuity in our 34 cases. The curves on the graph indicate the projected average final visual acuity for eyes with treated acute central retinal artery obstruction separated into 5 levels of presenting visual acuity. In patients with severe visual impairment at presentation (visual acuity light perception or worse, lines 1 and 2 in Fig. 1 ) the likelihood of significant improvement in visual acuity appears to be small even if the duration has been only 2-4 hours. In contrast the average patient with relatively good presenting vision (visual acuity > counting fingers at 1 m, line 5 in Fig. 1) can attain a final visual acuity of approximately 6/30 even after a duration of 36-48 hours.
The precise relationship between presenting visual acuity and the degree of impairment of blood flow into the eye via the central retinal artery is not known. Experimental total central retinal artery obstructions in rhesus monkeys of up to 90 minutes' duration have been shown to cause no persistent ophthalmoscopic, angiographic, electrophysiological, or morphological damage to the retina.'4 Nonperfused retina in monkeys and cats appears to survive central retinal artery occlusion for prolonged periods because of the metabolic contributions of the intact choroidal circulation to the retina.'" Partially perfused retina, which appears to be present in almost all human clinical cases of central retinal artery obstruction,'3 is probably able to survive in a reversible preinfarction state for a much longer period of time. Restoration of the central retinal artery blood flow, either spontaneously or in response to therapy, permits recovery of visual acuity to a level determined by the viability of the retina at that time. Reduction of the functional severity of the central retinal artery obstruction therapeutically, by means such as abrupt lowering of the intraocular pressure by paracentesis and increasing the retinal oxygenation by inhalation therapy with 95% oxygen and 5% carbon dioxide, may prolong the period of retinal viability in a preinfarction ischaemic state. Such treatments may, in effect, provide time for the retinal arterial circulation to undergo alterations that improve retinal perfusion by bypassing or reopening the obstructed artery.
The prognostic significance of the actual recorded a and b wave voltages on the electroretinograms in our cases was difficult to assess. A considerable overlap existed between the range of voltages in the 'normal' fellow eyes and that of the affected eyes. This difficulty has been alluded to previously by Henkes,16 who noted that only 22% of his patients with central retinal artery obstruction had a normal ERG in the unaffected eye. The prognostic significance of fluorescein angiographic intervals was also difficult to assess. We encountered problems of reproducibility in measurement of the various angiographic intervals. Because of these difficulties, we have not found these studies particularly useful as prognostic indicators of the likeli-916 group.bmj.com on November 7, 2017 -Published by http://bjo.bmj.com/ Downloaded from Visual prognosis following treatment of acute central retinal artery obstruction hood of significant visual recovery in our patients. However, the value of these studies as prognostic tools is still being evaluated.
We have attempted to compare the visual recovery rate of our patients with that reported by other investigators.
Lorentzen17 reported that none of his 12 cases of central retinal artery obstruction (treatment not specified) showed significant visual improvement (by our criteria). Karjalainen18 reported long-term follow-up of 53 patients with prior acute central retinal artery obstruction. Ten of the 53 cases (19%) showed significant visual improvement (by our criteria). However, 12% of the eyes had a patent cilioretinal artery. Henkes' reported that 5 of his 19 cases (26%) with visual acuities recorded for both presenting and follow-up examinations showed significant visual acuity improvement (by our criteria) after treatment with intravenous and oral vasodilators. He did not state whether or not any of his cases had a fovea-sparing cilioretinal artery, which is known to improve the visual prognosis. ' Brown and Shields' reported on the prevalence and prognostic implications of a patent cilioretinal artery in a retrospective study of acute central retinal artery obstructions. Among their 107 patients 28 (26%) had a patent cilioretinal artery in the affected eye. In 5 of these 28 cases less than half the papillomacular bundle was supplied by the patent cilioretinal artery. Not one of these cases showed significant visual improvement or achieved a visual acuity better than counting fingers. In 11 of these 28 cases the patent cilioretinal artery supplied more than half of the papillomacular bundle but did not spare the fovea. The follow-up visual acuities in these cases ranged from 6/30 to counting fingers. Twelve of their cases had a fovea-sparing cilioretinal artery. All but one of these cases achieved a final visual acuity of 6/30 or better. The authors commented that in acute central retinal artery obstruction with a fovea-sparing cilioretinal artery, 'there is about a 91% chance that eventual visual acuity will be in the range from 6/6 to 6/24 and about an 83% chance it will range from 6/6 to 6/15'.
Conclusion
This uncontrolled study does not prove the efficacy of our treatment regimen. Without a double-masked controlled study one is unable to exclude the possibility that several or all of our cases that showed significant visual improvement after treatment might also have improved without treatment. The incidence of spontaneous, significant improvement in visual acuity after central retinal artery obstruction is unknown. However, it is well known that occasional cases of acute central retinal artery obstruction without a fovea-sparing cilioretinal artery show a marked recovery of visual acuity without treatment. The authors recognise that further investigation is needed to clarify the efficacy of treatment in these cases. However, we can conclude from our study that a completely dismal prognosis for recovery of useful vision in eyes with acute central retinal artery obstruction is probably unwarranted.
